Detailed Information on Publication Record
2024
The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan
ZACHOVA, K., E. BARTHELDYOVA, F. HUBATKA, M. KRUPKA, N. ODEHNALOVA et. al.Basic information
Original name
The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan
Authors
ZACHOVA, K. (203 Czech Republic), E. BARTHELDYOVA (203 Czech Republic), F. HUBATKA (203 Czech Republic), M. KRUPKA (203 Czech Republic), N. ODEHNALOVA (203 Czech Republic), P. TURANEK KNOTIGOVA, Naděžda VAŠKOVICOVÁ (203 Czech Republic, belonging to the institution), K. SLOUPENSKA (203 Czech Republic), R. HROMADKA (203 Czech Republic), E. PAULOVICOVA (703 Slovakia), R. EFFENBERG (203 Czech Republic), M. LEDVINAE (203 Czech Republic), M. RASKA (203 Czech Republic) and J. TURANEKA (203 Czech Republic)
Edition
Carbohydrate Polymers, London, ELSEVIER SCI LTD, 2024, 0144-8617
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 11.200 in 2022
Organization unit
Faculty of Medicine
UT WoS
001183883300001
Keywords in English
Liposomes; Mannan; Recombinant protein; Adjuvants; Bioconjugation; Oxime ligation
Tags
International impact, Reviewed
Změněno: 16/8/2024 07:38, Mgr. Tereza Miškechová
Abstract
V originále
Anti-viral and anti-tumor vaccines aim to induce cytotoxic CD8+ T cells (CTL) and antibodies. Conserved protein antigens, such as p24 from human immunodeficiency virus, represent promising component for elicitation CTLs, nevertheless with suboptimal immunogenicity, if formulated as recombinant protein. To enhance immunogenicity and CTL response, recombinant proteins may be targeted to dendritic cells (DC) for cross presentation on MHCI, where mannose receptor and/or other lectin receptors could play an important role. Here, we constructed liposomal carrier-based vaccine composed of recombinant p24 antigen bound by metallochelating linkage onto surface of nanoliposomes with surface mannans coupled by aminooxy ligation. Generated mannosylated proteonanoliposomes were analyzed by dynamic light scattering, isothermal titration, and electron microscopy. Using murine DC line MutuDC and murine bone marrow derived DC (BMDC) we evaluated their immunogenicity and immunomodulatory activity. We show that p24 mannosylated proteonanoliposomes activate DC for enhanced MHCI, MHCII and CD40, CD80, and CD86 surface expression both on MutuDC and BMDC. p24 mannosylated liposomes were internalized by MutuDC with p24 intracellular localization within 1 to 3 h. The combination of metallochelating and aminooxy ligation could be used simultaneously to generate nanoliposomal adjuvanted recombinant protein-based vaccines versatile for combination of recombinant antigens relevant for antibody and CTL elicitation.